Physician profile
Jay Heintz
NPI 1194928168
$10,283.46
in general payments reported to CMS, 2019-2025
47 companies · $1,992 in 2025
The $1,992 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,244 · 2020: $891 · 2021: $1,402 · 2022: $1,763 · 2023: $1,115 · 2024: $1,876 · 2025: $1,992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,798 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,798.11 |
| Education | $185.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,614.93 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, Bulkamid |
| Astellas Pharma US INC | $1,057.65 | 2019-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $832.92 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $801.78 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $607.34 | 2019-2025 | |
| Coloplast Corp | $581.98 | 2019-2025 | Altis, Titan |
| Abbvie INC. | $489.47 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $484.57 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $380.46 | 2019-2024 | Aveed, Xiaflex |
| Urogen Pharma, INC. | $293.88 | 2022-2025 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $279.80 | 2019-2025 | Provenge |
| Allergan, INC. | $267.62 | 2019-2022 | |
| Acerus Pharmaceuticals Corporation | $264.06 | 2021-2022 | |
| Janssen Biotech, INC. | $256.24 | 2024-2025 | Erleada |
| Axonics, INC. | $226.02 | 2020-2024 | Bulkamid |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $201.22 | 2021-2022 | |
| Photocure INC | $197.68 | 2022-2025 | Cysview |
| Medtronic USA, INC. | $144.69 | 2019-2020 | |
| Procept Biorobotics Corporation | $132.31 | 2025 | |
| Medtronic, INC. | $116.05 | 2022-2025 | Interstim |
| Tolmar, INC. | $108.15 | 2024-2025 | Eligard, Jatenzo |
| Urovant Sciences INC | $100.10 | 2022 | |
| Halozyme INC | $90.83 | 2023 | |
| Endo USA, INC. | $89.09 | 2024-2025 | Aveed, Xiaflex |
| Merck Sharp & Dohme LLC | $59.99 | 2022-2023 | Lynparza, Keytruda |
| Myriad Genetic Laboratories, INC. | $52.23 | 2024 | Prolaris |
| Progenics Pharmaceuticals, INC. | $51.41 | 2021-2023 | Pylarify |
| 180 Medical, INC. | $49.66 | 2022-2025 | |
| Teleflex LLC | $48.05 | 2025 | Barrigel |
| Ferring Pharmaceuticals INC. | $43.53 | 2024-2025 | Adstiladrin |
| Mission Pharmacal Company | $38.23 | 2021-2024 | Uribel Tabs |
| Novartis Pharmaceuticals Corporation | $31.80 | 2025 | |
| Accord Healthcare, INC. | $27.75 | 2025 | |
| Biotissue Holdings INC. | $25.38 | 2021 | |
| Laborie Medical Technologies Corp. | $25.11 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Blue Earth Diagnostics | $24.61 | 2022 | |
| Calyxo, INC. | $22.72 | 2025 | Cvac Aspiration System |
| Cook Medical LLC | $19.01 | 2024 | Cook |
| Hollister Incorporated | $17.83 | 2024 | |
| Mallinckrodt Enterprises LLC | $17.72 | 2019 | |
| Duchesnay USA Incorporated | $17.54 | 2019 | |
| Olympus America INC. | $17.40 | 2025 | Cysto-Nephro Videoscope |
| Clinigen, INC. | $17.24 | 2020 | |
| Therapeuticsmd, INC. | $16.60 | 2019 | |
| Azurity Pharmaceuticals, INC. | $15.42 | 2025 | Azmiro |
| C. R. Bard, INC. & Subsidiaries | $13.67 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Heintz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.